Erratum

In the Original Article, "Omalizumab chronic spontaneous urticaria: Efficacy, safety, predictors of treatment outcome, and time to response" (Ann Allergy Asthma Immunol. 2018;121:474-478), the title should have been set as "Omalizumab in chronic spontaneous urticaria: Efficacy, safety, predictors of treatment outcome, and time to response."

https://ift.tt/2TPnzwy